Hill-Rom

AvaSure Appoints Technology Veteran Paula Cobb as Vice President of Marketing

Retrieved on: 
Tuesday, April 23, 2024
BD (company), Product marketing, Cerner, Sport, Marketing, Communication, McKesson Corporation, Hill-Rom, Knowledge, Health, Enterprise, Management

BELMONT, Mich., April 23, 2024 /PRNewswire/ -- AvaSure®, a market leader in acute virtual sitting and virtual nursing, proudly announces the appointment of Paula Cobb as Vice President of Marketing. Cobb joins AvaSure to spearhead the company's marketing strategy, amplify AvaSure's presence, and share its proven clinical and financial results on a broader scale.

Key Points: 
  • BELMONT, Mich., April 23, 2024 /PRNewswire/ -- AvaSure®, a market leader in acute virtual sitting and virtual nursing, proudly announces the appointment of Paula Cobb as Vice President of Marketing.
  • Cobb joins AvaSure to spearhead the company's marketing strategy, amplify AvaSure's presence, and share its proven clinical and financial results on a broader scale.
  • "We are thrilled to welcome Paula Cobb to the AvaSure team," said Adam McMullin, CEO of AvaSure.
  • Cobb brings a wealth of marketing experience to AvaSure, having previously served as Vice President of Enterprise Marketing at Blackbaud, where she led groundbreaking campaigns for Fortune 500 accounts in financial services, healthcare, and sports and entertainment.

Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Hill-Rom, Microsoft, Patient, Conditional sentence, Trauma, TigerConnect, Big data, Investment, Patient safety, NEC, Jive Software, Automation, Partnership, Stryker Corporation, Software, Cisco, Baxter International, Safety, OPN, Privacy, Health, Advantage, Communication, Knowledge, Hospital, Research, Growth, Market development, UC, OCI, Operating, EHR, Physician, Nursing

Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.

Key Points: 
  • Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.
  • Moreover, the unique communication needs of physicians, including the requirement for secure and confidential communication channels, further highlights the importance of dedicated physician communication solutions within the clinical communication and collaboration market.
  • Clinical Communication & Collaboration Market Dynamics:
    Key Market Players of Clinical Communication & Collaboration Industry:
    Prominent players in the Clinical Communication and Collaboration market include Avaya LLC (US), Oracle (US), Cisco Systems, Inc. (US), Microsoft Corporation (US), Baxter International (Hillrom) (US), symplr (US), NEC Corporation (Japan), Spok Inc. (US), Vocera Communications (Stryker) (US), Ascom Holding AG (Switzerland), Everbridge (US), Hidden Brains InfoTech.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Clinical Communication and Collaboration market.

Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Hill-Rom, Microsoft, Patient, Conditional sentence, Trauma, TigerConnect, Big data, Investment, Patient safety, NEC, Jive Software, Automation, Partnership, Stryker Corporation, Software, Cisco, Baxter International, Safety, OPN, Privacy, Health, Advantage, Communication, Knowledge, Hospital, Research, Growth, Market development, UC, OCI, Operating, EHR, Physician, Nursing

Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.

Key Points: 
  • Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.
  • Moreover, the unique communication needs of physicians, including the requirement for secure and confidential communication channels, further highlights the importance of dedicated physician communication solutions within the clinical communication and collaboration market.
  • Clinical Communication & Collaboration Market Dynamics:
    Key Market Players of Clinical Communication & Collaboration Industry:
    Prominent players in the Clinical Communication and Collaboration market include Avaya LLC (US), Oracle (US), Cisco Systems, Inc. (US), Microsoft Corporation (US), Baxter International (Hillrom) (US), symplr (US), NEC Corporation (Japan), Spok Inc. (US), Vocera Communications (Stryker) (US), Ascom Holding AG (Switzerland), Everbridge (US), Hidden Brains InfoTech.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Clinical Communication and Collaboration market.

NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

Retrieved on: 
Tuesday, February 27, 2024
Biotechnology, Health, Radiology, Pharmaceutical, Oncology, Eli Lilly, CFO, Acquisition, OPCH, Mallinckrodt, Syneos Health, Hospira, SVP, OTC, ENOV, Growth, BioMarin Pharmaceutical, MBA, Hill-Rom, NorthStar, CDMO, Doctor of Philosophy, University, Engineering, Partnership, Radiopharmaceutical, McKinsey & Company, Patient, Invacare, IVC, Northwestern University, Health technology, Cancer, Management

NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024.

Key Points: 
  • NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024.
  • "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar.
  • She is currently a Board Director for Enovis Corporation (NYSE: ENOV), Option Care Health (NASDAQ: OPCH) and BioMarin Pharmaceutical (NASDAQ: BMRN).
  • “2024 and the next few years will be critical for NorthStar,” said Frank Scholz, Ph.D., NorthStar President and Chief Executive Officer.

Hallmark Appoints Healthcare Leader and Patient Experience Innovator Patrick T. Ryan as Board Chairman

Retrieved on: 
Tuesday, February 13, 2024
Data Management, Health, Technology, Practice Management, Health Technology, Software, General Health, Summit Partners, Press Ganey Associates, Affiliated Managers Group, Growth, Patient, Hill-Rom, Safety, Organization, Modern Healthcare, Workforce, Atrius Health

Hallmark Health Care Solutions , a healthcare workforce management technology company, today announced the appointment of Patrick T. Ryan as non-executive Chairman of its Board of Directors.

Key Points: 
  • Hallmark Health Care Solutions , a healthcare workforce management technology company, today announced the appointment of Patrick T. Ryan as non-executive Chairman of its Board of Directors.
  • Ryan brings more than 35 years of experience as an entrepreneur, leader, and CEO of numerous healthcare service organizations.
  • Ryan was recognized by Modern Healthcare as one of the industry’s 100 Most Influential People in Healthcare of 2023.
  • “Pat brings an unparalleled passion and experience collaborating with healthcare systems and providers to improve patient, clinical, and financial outcomes,” said Bruce Cerullo, CEO of Hallmark.

CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors

Retrieved on: 
Thursday, February 8, 2024
Baxter, Connect, CTS, Growth, Hill-Rom, Procept

Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets.

Key Points: 
  • Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets.
  • In that role, Ms. Dodrill successfully integrated two former Hillrom business units into Baxter.
  • Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ: PRCT), a commercial stage surgical robotics company, serving on the audit and compensation committees.
  • "CTS is pleased to welcome Amy Dodrill to the CTS board.

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

Retrieved on: 
Wednesday, January 31, 2024
Hykes, Knowledge, Medtronic, Jan Vansina, Patient, Boston Scientific, MBA, Information system, Employment, CRM, University, Cardiac surgery, Hill-Rom, BBA, Management

Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors since 2022

Key Points: 
  • Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors since 2022
    MINNEAPOLIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc .
  • (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the appointment of Kevin Hykes as the Company’s new President and Chief Executive Officer, effective February 12.
  • Yared will retire from the Company and resign his Board seat concurrent with Hykes’ appointment and has agreed to consult with the Company to ensure a seamless transition.
  • Hykes currently serves as the President and CEO of Augmedics, a pioneer in augmented reality surgical navigation.

BioMarin Announces Governance Enhancements and Value Creation Initiatives

Retrieved on: 
Wednesday, December 20, 2023
Adverum Biotechnologies, University, Ambit Biosciences, Daiichi Sankyo, Hill-Rom, Indiana University, Harvard Law School, Baxter, Acceleration, Strategy, Palmer, Pfizer, Biotechnology Innovation Organization, Invacare, Eli Lilly, Hospira, Pediatrics, Chairperson, The Nature Conservancy, Genzyme, American Cancer Society, Therapy, Goldman Sachs, M.B.A, BMRN, ImmunoGen, DSM-IV codes, Shire (pharmaceutical company), IPO, Patient, Proteostasis, BioMarin Pharmaceutical, Corporate development, Dentsply Sirona, Senior, Syneos Health, Iovance Biotherapeutics, Sclerosis, Acquisition, SAN, CIO, Eli Lilly and Company, Interim, Bristol Myers Squibb, Information technology, Management

SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.

Key Points: 
  • SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.
  • "Today's announcements will strengthen our ability to drive better outcomes for patients with genetic diseases and deliver value to all stakeholders.
  • BioMarin plays a pivotal role in the treatment of genetic diseases thanks to its globally leading rare-disease portfolio.
  • We believe the changes announced today put BioMarin in the best position to realize its full potential, and we support Alexander Hardy as the right leader for this chapter of BioMarin's value creation story.

Walking Aid Market to Boom: $5.2 Billion Industry by 2034 as Disabilities and Aging Population Rise | Future Market Insights, Inc.

Retrieved on: 
Tuesday, December 12, 2023
Associate, Price analysis, Safety, Hill-Rom, Prevalence, Medline Industries, Osteoarthritis, Cardinal Health, Walking, Competitive landscape, Disability, Patient, Strategic planning, Rheumatoid arthritis, Cane, Arthritis, Mount Everest, Invacare, Weakness, Automation, Ageing, Cardinal, Arthralgia, Growth, Hospital, Quality of life, FMI, Crutch, Pharmaceutical industry, Nursing, Pet industry, Retail

NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024. Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.

Key Points: 
  • NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024.
  • Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.
  • Request Exclusive Sample Report: Walking Aid Market Strategic Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-18649
    Multiple factors are expected to stimulate the growth of the walking aid market during the assessment period.
  • These include the rising prevalence of disabilities, increasing cases of arthritis, a growing geriatric population, and favorable government initiatives.

Walking Aid Market to Boom: $5.2 Billion Industry by 2034 as Disabilities and Aging Population Rise | Future Market Insights, Inc.

Retrieved on: 
Tuesday, December 12, 2023
Associate, Price analysis, Safety, Hill-Rom, Prevalence, Medline Industries, Osteoarthritis, Cardinal Health, Walking, Competitive landscape, Disability, Patient, Strategic planning, Rheumatoid arthritis, Cane, Arthritis, Mount Everest, Invacare, Weakness, Automation, Ageing, Cardinal, Arthralgia, Growth, Hospital, Quality of life, FMI, Crutch, Pharmaceutical industry, Nursing, Pet industry, Retail

NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024. Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.

Key Points: 
  • NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024.
  • Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.
  • Request Exclusive Sample Report: Walking Aid Market Strategic Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-18649
    Multiple factors are expected to stimulate the growth of the walking aid market during the assessment period.
  • These include the rising prevalence of disabilities, increasing cases of arthritis, a growing geriatric population, and favorable government initiatives.